Literature DB >> 24439337

The pivotal role of FDG-PET/CT in modern medicine.

Søren Hess1, Björn A Blomberg2, Hongyun June Zhu3, Poul Flemming Høilund-Carlsen4, Abass Alavi5.   

Abstract

The technology behind positron emission tomography (PET) and the most widely used tracer, 2-deoxy-2-[18F]fluoro-D-glucose (FDG), were both conceived in the 1970s, but the latest decade has witnessed a rapid emergence of FDG-PET as an effective imaging technique. This is not least due to the emergence of hybrid scanners combining PET with computed tomography (PET/CT). Molecular imaging has enormous potential for advancing biological research and patient care, and FDG-PET/CT is currently the most widely used technology in this domain. In this review, we discuss contemporary applications of FDG-PET and FDG-PET/CT as well as novel developments in quantification and potential future indications including the emerging new modality PET/magnetic resonance imaging.
Copyright © 2014 AUR. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  2-deoxy-2-[18F]fluoro-D-glucose; FDG; PET/CT; Positron emission tomography/computed tomography; molecular imaging

Mesh：

Substances：

Year:  2014        PMID： 24439337     DOI： 10.1016/j.acra.2013.11.002

Source DB:  PubMed          Journal:  Acad Radiol        ISSN： 1076-6332            Impact factor:   3.173


  33 in total

1.  Distinctive FDG-PET/CT Findings in Acute Neurological Hospital Care.

Authors:  Josef G Heckmann; Wolfgang Niedermeier; Markus Büchner; Bernhard Scher
Journal:  Neurohospitalist       Date:  2018-10-15

2.  Effect of blood glucose level on standardized uptake value (SUV) in 18F- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements.

Authors:  Mahsa Eskian; Abass Alavi; MirHojjat Khorasanizadeh; Benjamin L Viglianti; Hans Jacobsson; Tara D Barwick; Alipasha Meysamie; Sun K Yi; Shingo Iwano; Bohdan Bybel; Federico Caobelli; Filippo Lococo; Joaquim Gea; Antonio Sancho-Muñoz; Jukka Schildt; Ebru Tatcı; Constantin Lapa; Georgia Keramida; Michael Peters; Raef R Boktor; Joemon John; Alexander G Pitman; Tomasz Mazurek; Nima Rezaei
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10-22       Impact factor: 9.236

Review 3.  Clinical utility of F-18 FDG PET-CT in the initial evaluation of lung cancer.

Authors:  Poul Henning Madsen; Paw Christian Holdgaard; Janne Buck Christensen; Poul Flemming Høilund-Carlsen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-05-11       Impact factor: 9.236

Review 4.  The Empirical Foundations of Teleradiology and Related Applications: A Review of the Evidence.

Authors:  Rashid L Bashshur; Elizabeth A Krupinski; James H Thrall; Noura Bashshur
Journal:  Telemed J E Health       Date:  2016-09-01       Impact factor: 3.536

5.  PET-based imaging to detect and characterize cardiovascular disorders: Unavoidable path for the foreseeable future.

Authors:  Abass Alavi; Thomas J Werner; Poul Flemming Høilund-Carlsen
Journal:  J Nucl Cardiol       Date:  2017-09-12       Impact factor: 5.952

6.  An update on the unparalleled impact of FDG-PET imaging on the day-to-day practice of medicine with emphasis on management of infectious/inflammatory disorders.

Authors:  Abass Alavi; Søren Hess; Thomas J Werner; Poul Flemming Høilund-Carlsen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-09-04       Impact factor: 9.236

7.  Clinical value of FDG-PET/CT in bacteremia of unknown origin with catalase-negative gram-positive cocci or Staphylococcus aureus.

Authors:  Mette Bordinggaard Brøndserud; Court Pedersen; Flemming S Rosenvinge; Poul F Høilund-Carlsen; Søren Hess
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-02-20       Impact factor: 9.236

8.  Clinical value of FDG-PET/CT in suspected paraneoplastic syndromes: a retrospective analysis of 137 patients.

Authors:  Stine Bjørn Kristensen; Søren Hess; Henrik Petersen; Poul Flemming Høilund-Carlsen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-21       Impact factor: 9.236

Review 9.  Monitoring of anti-cancer treatment with (18)F-FDG and (18)F-FLT PET: a comprehensive review of pre-clinical studies.

Authors:  Mette Munk Jensen; Andreas Kjaer
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-10-12

10.  A pilot study on lung cancer detection based on regional metabolic activity distribution in digital low-dose 18F-FDG PET.

Authors:  Michael Messerli; Urs J Muehlematter; Saskia Fassbind; Daniel Franzen; Daniela A Ferraro; Martin W Huellner; Valerie Treyer; Alessandra Curioni-Fontecedro; Irene A Burger
Journal:  Br J Radiol       Date:  2021-02-02       Impact factor: 3.039
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.